 | • レポートコード：QYR2104Z2779 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、B型・C型肝炎診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（B型肝炎、C型肝炎）、用途別市場規模（免疫診断、核酸検査（NAT））、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・B型・C型肝炎診断の市場動向 ・企業の競争状況、市場シェア ・B型・C型肝炎診断の種類別市場規模（B型肝炎、C型肝炎） ・B型・C型肝炎診断の用途別市場規模（免疫診断、核酸検査（NAT）） ・B型・C型肝炎診断の北米市場規模2016-2027（アメリカ、カナダ） ・B型・C型肝炎診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・B型・C型肝炎診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・B型・C型肝炎診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・B型・C型肝炎診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche Diagnostics、Abbott、Siemens、Qiagen、Abbott、bioMérieux、Cepheid、Chembio Diagnostics、DiaSorin、Enzo Life Sciences、Hologic、MedMira、OraSure Technologies、Quest Diagnostics、Quidel Corp、Randox Laboratories） ・結論 |
Hepatitis B diagnostic tests include HBV serologic tests, molecular deoxyribonucleic acid (DNA) tests, histology tests, and laboratory tests. HBV serologic tests involve the measurement of antigens and antibodies. Hepatitis C diagnostic tests include anti-HCV serologic test, HCV recombinant immunoblot assay (RIBA) antibody test, and HCV molecular ribonucleic acid (RNA) testing. Anti-HCV is the serologic test used for screening.
The increasing demand for molecular diagnostic of HBV (hepatitis B virus) and HCV (hepatitis C virus) infections is one of the primary drivers for the growth of this market. Molecular diagnosis simplifies sample preparation for high-volume testing and includes identification and profiling of causative agents of infection and the quantification of pathogens to monitor durability of therapy; thus, resulting in sales of around 60% of the overall molecular diagnosis market. Additionally, new companies are also focusing on the development of new products, which, in turn, is expected to change market dynamics for the diagnosis of HBV and HCV infections. For instance, Cepheid recently announced a quantitative test that offers on-demand molecular testing for confirmation of infection and monitoring of HCV and has obtained CE-IVD (in vitro diagnostics) status under the European Directive on in-vitro diagnostic medical devices, making it one of the leading platforms for molecular diagnosis.
Market Analysis and Insights: Global Hepatitis B and C Diagnostics Market
The global Hepatitis B and C Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hepatitis B and C Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hepatitis B and C Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hepatitis B and C Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hepatitis B and C Diagnostics market.
Global Hepatitis B and C Diagnostics Scope and Market Size
Hepatitis B and C Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis B and C Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Hepatitis B
Hepatitis C
Segment by Application
Immunodiagnostics
Nucleic Acid Test (NAT)
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche Diagnostics
Abbott
Siemens
Qiagen
Abbott
bioMérieux
Cepheid
Chembio Diagnostics
DiaSorin
Qiagen
Abbott
MedMira
OraSure Technologies
Quest Diagnostics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatitis B and C Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hepatitis B
1.2.3 Hepatitis C
1.3 Market by Application
1.3.1 Global Hepatitis B and C Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Immunodiagnostics
1.3.3 Nucleic Acid Test (NAT)
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hepatitis B and C Diagnostics Market Perspective (2016-2027)
2.2 Hepatitis B and C Diagnostics Growth Trends by Regions
2.2.1 Hepatitis B and C Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hepatitis B and C Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Hepatitis B and C Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Hepatitis B and C Diagnostics Industry Dynamic
2.3.1 Hepatitis B and C Diagnostics Market Trends
2.3.2 Hepatitis B and C Diagnostics Market Drivers
2.3.3 Hepatitis B and C Diagnostics Market Challenges
2.3.4 Hepatitis B and C Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hepatitis B and C Diagnostics Players by Revenue
3.1.1 Global Top Hepatitis B and C Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Hepatitis B and C Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Hepatitis B and C Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hepatitis B and C Diagnostics Revenue
3.4 Global Hepatitis B and C Diagnostics Market Concentration Ratio
3.4.1 Global Hepatitis B and C Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatitis B and C Diagnostics Revenue in 2020
3.5 Hepatitis B and C Diagnostics Key Players Head office and Area Served
3.6 Key Players Hepatitis B and C Diagnostics Product Solution and Service
3.7 Date of Enter into Hepatitis B and C Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hepatitis B and C Diagnostics Breakdown Data by Type
4.1 Global Hepatitis B and C Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Hepatitis B and C Diagnostics Forecasted Market Size by Type (2022-2027)
5 Hepatitis B and C Diagnostics Breakdown Data by Application
5.1 Global Hepatitis B and C Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Hepatitis B and C Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Hepatitis B and C Diagnostics Market Size (2016-2027)
6.2 North America Hepatitis B and C Diagnostics Market Size by Type
6.2.1 North America Hepatitis B and C Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Hepatitis B and C Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Hepatitis B and C Diagnostics Market Size by Type (2016-2027)
6.3 North America Hepatitis B and C Diagnostics Market Size by Application
6.3.1 North America Hepatitis B and C Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Hepatitis B and C Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Hepatitis B and C Diagnostics Market Size by Application (2016-2027)
6.4 North America Hepatitis B and C Diagnostics Market Size by Country
6.4.1 North America Hepatitis B and C Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Hepatitis B and C Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Hepatitis B and C Diagnostics Market Size (2016-2027)
7.2 Europe Hepatitis B and C Diagnostics Market Size by Type
7.2.1 Europe Hepatitis B and C Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Hepatitis B and C Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Hepatitis B and C Diagnostics Market Size by Type (2016-2027)
7.3 Europe Hepatitis B and C Diagnostics Market Size by Application
7.3.1 Europe Hepatitis B and C Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Hepatitis B and C Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Hepatitis B and C Diagnostics Market Size by Application (2016-2027)
7.4 Europe Hepatitis B and C Diagnostics Market Size by Country
7.4.1 Europe Hepatitis B and C Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Hepatitis B and C Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Hepatitis B and C Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Hepatitis B and C Diagnostics Market Size by Type
8.2.1 Asia-Pacific Hepatitis B and C Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hepatitis B and C Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hepatitis B and C Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Hepatitis B and C Diagnostics Market Size by Application
8.3.1 Asia-Pacific Hepatitis B and C Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hepatitis B and C Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hepatitis B and C Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Hepatitis B and C Diagnostics Market Size by Region
8.4.1 Asia-Pacific Hepatitis B and C Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hepatitis B and C Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hepatitis B and C Diagnostics Market Size (2016-2027)
9.2 Latin America Hepatitis B and C Diagnostics Market Size by Type
9.2.1 Latin America Hepatitis B and C Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Hepatitis B and C Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Hepatitis B and C Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Hepatitis B and C Diagnostics Market Size by Application
9.3.1 Latin America Hepatitis B and C Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Hepatitis B and C Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Hepatitis B and C Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Hepatitis B and C Diagnostics Market Size by Country
9.4.1 Latin America Hepatitis B and C Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Hepatitis B and C Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hepatitis B and C Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Hepatitis B and C Diagnostics Market Size by Type
10.2.1 Middle East & Africa Hepatitis B and C Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hepatitis B and C Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hepatitis B and C Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Hepatitis B and C Diagnostics Market Size by Application
10.3.1 Middle East & Africa Hepatitis B and C Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hepatitis B and C Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hepatitis B and C Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Hepatitis B and C Diagnostics Market Size by Country
10.4.1 Middle East & Africa Hepatitis B and C Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hepatitis B and C Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Details
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Hepatitis B and C Diagnostics Introduction
11.1.4 Roche Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.1.5 Roche Diagnostics Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Hepatitis B and C Diagnostics Introduction
11.2.4 Abbott Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.2.5 Abbott Recent Development
11.3 Siemens
11.3.1 Siemens Company Details
11.3.2 Siemens Business Overview
11.3.3 Siemens Hepatitis B and C Diagnostics Introduction
11.3.4 Siemens Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.3.5 Siemens Recent Development
11.4 Qiagen
11.4.1 Qiagen Company Details
11.4.2 Qiagen Business Overview
11.4.3 Qiagen Hepatitis B and C Diagnostics Introduction
11.4.4 Qiagen Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.4.5 Qiagen Recent Development
11.5 Abbott
11.5.1 Abbott Company Details
11.5.2 Abbott Business Overview
11.5.3 Abbott Hepatitis B and C Diagnostics Introduction
11.5.4 Abbott Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.5.5 Abbott Recent Development
11.6 bioMérieux
11.6.1 bioMérieux Company Details
11.6.2 bioMérieux Business Overview
11.6.3 bioMérieux Hepatitis B and C Diagnostics Introduction
11.6.4 bioMérieux Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.6.5 bioMérieux Recent Development
11.7 Cepheid
11.7.1 Cepheid Company Details
11.7.2 Cepheid Business Overview
11.7.3 Cepheid Hepatitis B and C Diagnostics Introduction
11.7.4 Cepheid Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.7.5 Cepheid Recent Development
11.8 Chembio Diagnostics
11.8.1 Chembio Diagnostics Company Details
11.8.2 Chembio Diagnostics Business Overview
11.8.3 Chembio Diagnostics Hepatitis B and C Diagnostics Introduction
11.8.4 Chembio Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.8.5 Chembio Diagnostics Recent Development
11.9 DiaSorin
11.9.1 DiaSorin Company Details
11.9.2 DiaSorin Business Overview
11.9.3 DiaSorin Hepatitis B and C Diagnostics Introduction
11.9.4 DiaSorin Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.9.5 DiaSorin Recent Development
11.10 Enzo Life Sciences
11.10.1 Enzo Life Sciences Company Details
11.10.2 Enzo Life Sciences Business Overview
11.10.3 Enzo Life Sciences Hepatitis B and C Diagnostics Introduction
11.10.4 Enzo Life Sciences Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.10.5 Enzo Life Sciences Recent Development
11.11 Hologic
11.11.1 Hologic Company Details
11.11.2 Hologic Business Overview
11.11.3 Hologic Hepatitis B and C Diagnostics Introduction
11.11.4 Hologic Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.11.5 Hologic Recent Development
11.12 MedMira
11.12.1 MedMira Company Details
11.12.2 MedMira Business Overview
11.12.3 MedMira Hepatitis B and C Diagnostics Introduction
11.12.4 MedMira Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.12.5 MedMira Recent Development
11.13 OraSure Technologies
11.13.1 OraSure Technologies Company Details
11.13.2 OraSure Technologies Business Overview
11.13.3 OraSure Technologies Hepatitis B and C Diagnostics Introduction
11.13.4 OraSure Technologies Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.13.5 OraSure Technologies Recent Development
11.14 Quest Diagnostics
11.14.1 Quest Diagnostics Company Details
11.14.2 Quest Diagnostics Business Overview
11.14.3 Quest Diagnostics Hepatitis B and C Diagnostics Introduction
11.14.4 Quest Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.14.5 Quest Diagnostics Recent Development
11.15 Quidel Corp
11.15.1 Quidel Corp Company Details
11.15.2 Quidel Corp Business Overview
11.15.3 Quidel Corp Hepatitis B and C Diagnostics Introduction
11.15.4 Quidel Corp Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.15.5 Quidel Corp Recent Development
11.16 Randox Laboratories
11.16.1 Randox Laboratories Company Details
11.16.2 Randox Laboratories Business Overview
11.16.3 Randox Laboratories Hepatitis B and C Diagnostics Introduction
11.16.4 Randox Laboratories Revenue in Hepatitis B and C Diagnostics Business (2016-2021)
11.16.5 Randox Laboratories Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Hepatitis B and C Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hepatitis B
Table 3. Key Players of Hepatitis C
Table 4. Global Hepatitis B and C Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Hepatitis B and C Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hepatitis B and C Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Hepatitis B and C Diagnostics Market Share by Regions (2016-2021)
Table 8. Global Hepatitis B and C Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Hepatitis B and C Diagnostics Market Share by Regions (2022-2027)
Table 10. Hepatitis B and C Diagnostics Market Trends
Table 11. Hepatitis B and C Diagnostics Market Drivers
Table 12. Hepatitis B and C Diagnostics Market Challenges
Table 13. Hepatitis B and C Diagnostics Market Restraints
Table 14. Global Hepatitis B and C Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Hepatitis B and C Diagnostics Market Share by Players (2016-2021)
Table 16. Global Top Hepatitis B and C Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B and C Diagnostics as of 2020)
Table 17. Ranking of Global Top Hepatitis B and C Diagnostics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Hepatitis B and C Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Hepatitis B and C Diagnostics Product Solution and Service
Table 21. Date of Enter into Hepatitis B and C Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hepatitis B and C Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Hepatitis B and C Diagnostics Revenue Market Share by Type (2016-2021)
Table 25. Global Hepatitis B and C Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Hepatitis B and C Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Hepatitis B and C Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Hepatitis B and C Diagnostics Revenue Market Share by Application (2016-2021)
Table 29. Global Hepatitis B and C Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Hepatitis B and C Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Hepatitis B and C Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Hepatitis B and C Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Hepatitis B and C Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Hepatitis B and C Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Hepatitis B and C Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Hepatitis B and C Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Hepatitis B and C Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Hepatitis B and C Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Hepatitis B and C Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Hepatitis B and C Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Hepatitis B and C Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Hepatitis B and C Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Hepatitis B and C Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Hepatitis B and C Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Hepatitis B and C Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Hepatitis B and C Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Hepatitis B and C Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Hepatitis B and C Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Hepatitis B and C Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Hepatitis B and C Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Hepatitis B and C Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Hepatitis B and C Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Hepatitis B and C Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Hepatitis B and C Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Hepatitis B and C Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Hepatitis B and C Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Hepatitis B and C Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Hepatitis B and C Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Hepatitis B and C Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Hepatitis B and C Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Roche Diagnostics Company Details
Table 62. Roche Diagnostics Business Overview
Table 63. Roche Diagnostics Hepatitis B and C Diagnostics Product
Table 64. Roche Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 65. Roche Diagnostics Recent Development
Table 66. Abbott Company Details
Table 67. Abbott Business Overview
Table 68. Abbott Hepatitis B and C Diagnostics Product
Table 69. Abbott Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 70. Abbott Recent Development
Table 71. Siemens Company Details
Table 72. Siemens Business Overview
Table 73. Siemens Hepatitis B and C Diagnostics Product
Table 74. Siemens Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 75. Siemens Recent Development
Table 76. Qiagen Company Details
Table 77. Qiagen Business Overview
Table 78. Qiagen Hepatitis B and C Diagnostics Product
Table 79. Qiagen Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 80. Qiagen Recent Development
Table 81. Abbott Company Details
Table 82. Abbott Business Overview
Table 83. Abbott Hepatitis B and C Diagnostics Product
Table 84. Abbott Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 85. Abbott Recent Development
Table 86. bioMérieux Company Details
Table 87. bioMérieux Business Overview
Table 88. bioMérieux Hepatitis B and C Diagnostics Product
Table 89. bioMérieux Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 90. bioMérieux Recent Development
Table 91. Cepheid Company Details
Table 92. Cepheid Business Overview
Table 93. Cepheid Hepatitis B and C Diagnostics Product
Table 94. Cepheid Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 95. Cepheid Recent Development
Table 96. Chembio Diagnostics Company Details
Table 97. Chembio Diagnostics Business Overview
Table 98. Chembio Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 99. Chembio Diagnostics Recent Development
Table 100. DiaSorin Company Details
Table 101. DiaSorin Business Overview
Table 102. DiaSorin Hepatitis B and C Diagnostics Product
Table 103. DiaSorin Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 104. DiaSorin Recent Development
Table 105. Enzo Life Sciences Company Details
Table 106. Enzo Life Sciences Business Overview
Table 107. Enzo Life Sciences Hepatitis B and C Diagnostics Product
Table 108. Enzo Life Sciences Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 109. Enzo Life Sciences Recent Development
Table 110. Hologic Company Details
Table 111. Hologic Business Overview
Table 112. Hologic Hepatitis B and C Diagnostics Product
Table 113. Hologic Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 114. Hologic Recent Development
Table 115. MedMira Company Details
Table 116. MedMira Business Overview
Table 117. MedMira Hepatitis B and C Diagnostics Product
Table 118. MedMira Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 119. MedMira Recent Development
Table 120. OraSure Technologies Company Details
Table 121. OraSure Technologies Business Overview
Table 122. OraSure Technologies Hepatitis B and C Diagnostics Product
Table 123. OraSure Technologies Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 124. OraSure Technologies Recent Development
Table 125. Quest Diagnostics Company Details
Table 126. Quest Diagnostics Business Overview
Table 127. Quest Diagnostics Hepatitis B and C Diagnostics Product
Table 128. Quest Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 129. Quest Diagnostics Recent Development
Table 130. Quidel Corp Company Details
Table 131. Quidel Corp Business Overview
Table 132. Quidel Corp Hepatitis B and C Diagnostics Product
Table 133. Quidel Corp Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 134. Quidel Corp Recent Development
Table 135. Randox Laboratories Company Details
Table 136. Randox Laboratories Business Overview
Table 137. Randox Laboratories Hepatitis B and C Diagnostics Product
Table 138. Randox Laboratories Revenue in Hepatitis B and C Diagnostics Business (2016-2021) & (US$ Million)
Table 139. Randox Laboratories Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hepatitis B and C Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Hepatitis B Features
Figure 3. Hepatitis C Features
Figure 4. Global Hepatitis B and C Diagnostics Market Share by Application: 2020 VS 2027
Figure 5. Immunodiagnostics Case Studies
Figure 6. Nucleic Acid Test (NAT) Case Studies
Figure 7. Hepatitis B and C Diagnostics Report Years Considered
Figure 8. Global Hepatitis B and C Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Hepatitis B and C Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Hepatitis B and C Diagnostics Market Share by Regions: 2020 VS 2027
Figure 11. Global Hepatitis B and C Diagnostics Market Share by Regions (2022-2027)
Figure 12. Global Hepatitis B and C Diagnostics Market Share by Players in 2020
Figure 13. Global Top Hepatitis B and C Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B and C Diagnostics as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Hepatitis B and C Diagnostics Revenue in 2020
Figure 15. Global Hepatitis B and C Diagnostics Revenue Market Share by Type (2016-2021)
Figure 16. Global Hepatitis B and C Diagnostics Revenue Market Share by Type (2022-2027)
Figure 17. North America Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Hepatitis B and C Diagnostics Market Share by Type (2016-2027)
Figure 19. North America Hepatitis B and C Diagnostics Market Share by Application (2016-2027)
Figure 20. North America Hepatitis B and C Diagnostics Market Share by Country (2016-2027)
Figure 21. United States Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Hepatitis B and C Diagnostics Market Share by Type (2016-2027)
Figure 25. Europe Hepatitis B and C Diagnostics Market Share by Application (2016-2027)
Figure 26. Europe Hepatitis B and C Diagnostics Market Share by Country (2016-2027)
Figure 27. Germany Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Hepatitis B and C Diagnostics Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Hepatitis B and C Diagnostics Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Hepatitis B and C Diagnostics Market Share by Region (2016-2027)
Figure 37. China Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Hepatitis B and C Diagnostics Market Share by Type (2016-2027)
Figure 45. Latin America Hepatitis B and C Diagnostics Market Share by Application (2016-2027)
Figure 46. Latin America Hepatitis B and C Diagnostics Market Share by Country (2016-2027)
Figure 47. Mexico Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Hepatitis B and C Diagnostics Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Hepatitis B and C Diagnostics Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Hepatitis B and C Diagnostics Market Share by Country (2016-2027)
Figure 53. Turkey Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Hepatitis B and C Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Roche Diagnostics Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 57. Abbott Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 58. Siemens Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 59. Qiagen Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 60. Abbott Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 61. bioMérieux Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 62. Cepheid Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 63. Chembio Diagnostics Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 64. DiaSorin Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 65. Enzo Life Sciences Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 66. Hologic Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 67. MedMira Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 68. OraSure Technologies Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 69. Quest Diagnostics Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 70. Quidel Corp Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 71. Randox Laboratories Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界の肝炎診断検査市場規模・現状・予測（2021年-2027年） Hepatitis is inflammation of the liver tissue. Some people have no symptoms whereas others develop yellow discoloration of the skin and whites of the eyes, poor appetite, vomiting, tiredness, abdominal pain, or diarrhea. Hepatitis may be temporary (acute) or long term (chronic) depending on whether …- 世界の肝炎検査用溶液/診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hepatitis Test Solution/Diagnosis Market The global Hepatitis Test Solution/Diagnosis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…
- 世界のE型肝炎診断検査市場規模・現状・予測（2021年-2027年） Hepatitis E is a virus that affects your liver. Market Analysis and Insights: Global Hepatitis E Diagnostic Tests Market The global Hepatitis E Diagnostic Tests market size is projected to reach US$ 48 million by 2026, from US$ 42 million in 2019, at a CAGR of 2.2% during 2021-2026. With industry-st…
- 世界のB型肝炎感染症検査市場規模・現状・予測（2021年-2027年） Hepatitis B is a potentially life-threatening liver infection caused by the hepatitis B virus (HBV). It is a major global health problem. It can cause chronic infection and puts people at high risk of death from cirrhosis and liver cancer. Market Analysis and Insights: Global Hepatitis B Infectious …
- 世界のB型肝炎感染症検査市場規模・現状・予測（2021年-2027年） Hepatitis B is a potentially life-threatening liver infection caused by the hepatitis B virus (HBV). It is a major global health problem. It can cause chronic infection and puts people at high risk of death from cirrhosis and liver cancer. Market Analysis and Insights: Global Hepatitis B Infectious …